Weight-loss medications like the popular versions made by Denmark's Novo Nordisk A/S (CSE:NOVOb) and US peer Eli Lilly ...

Danish drug maker Novo Nordisk has struck partnerships with 10 Indian artificial intelligence (AI) startups to streamline its ...

Danish drug maker Novo Nordisk produces a GLP-1 Semaglutide, sold under brand names Ozempic and Rybelsus in Type 2 diabetes and Wegovy in obesity, which has been labelled a “weight-loss” wonder drug.

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Rival manufacturers fight for the right to sell weight loss drugsThere’s a new fight brewing between ...

The FDA updated its database of drugs in shortage to remove tirzepatide, which had sat on that list – along with related ...

The $200B GLP-1 market is set to expand with 16 new obesity drugs launching by 2029, challenging Novo Nordisk and Eli Lilly's dominance while addressing scalability and pricing concerns.

AT 11:12 p.m. in Shenzhen on Sunday, China’s least affordable city eased rules for homebuyers. Less than an hour later, the first batch of prospective customers showed up at a sales center for a ...

France has refused to endorse prescribing weight loss drug, Wegovy through its national insurance system, despite being on ...

Senator Elizabeth Warren told the Federal Trade Commission that the acquisition of contract manufacturer Catalent could ...

Peptide companies' are creating knock-off versions of these drugs that have not been approved by the FDA and contain ...

Zealand Pharma CEO Adam Steensberg said Friday that the company is working on a next-generation weight loss drug that’s ...

Animal health authorities in the Netherlands have discovered infections in livestock of a bluetongue variant, BTV12, for ...